UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): January 26, 2012
 
LANTHEUS MEDICAL IMAGING, INC.	
(Exact name of registrant as specified in its charter)	
 
Delaware	 	333-169785	 	51-0396366	
(State or other jurisdiction of incorporation)	 	(Commission File Number)	 	(IRS Employer Identification No.)	
 
331 Treble Cove Road, North Billerica, MA 01862	
(Address of principal executive offices) (Zip code)	
 	
Registrant’s telephone number, including area code: (978) 671-8001	
 
Not Applicable	
(Former name or former address, if changed since last report.)	
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o           Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o           Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o           Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o           Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
Item 1.01            Entry into a Material Definitive Agreement.
 
On January 26, 2012, the Company entered into an amendment of the terms of its existing revolving credit facility (“Revolver”) with a syndicate of banks and Bank of Montreal, as the administrative agent (the “Amendment”). The Amendment increases the applicable consolidated total leverage ratio, and decreases the consolidated interest coverage ratio, for certain fiscal quarters. Additionally, the Amendment modifies the Company’s ability to add back certain costs arising from the transfer of certain of its manufacturing operations and suppliers, as well as certain legal costs incurred in connection with claims made under its business interruption insurance policies, in calculating EBITDA in connection with the Revolver.  The Amendment is attached hereto as Exhibit 10.1 and incorporated herein by reference.
 
The foregoing summary does not purport to be complete and is qualified in its entirety by reference to the Amendment.
 
Item 9.01            Financial Statements and Exhibits
 
(d) Exhibits
 
Exhibit
Number	 	Description of Exhibits	
10.1	 	Amendment No. 2 to Credit Agreement, dated as of January 26, 2012, among Lantheus Medical Imaging, Inc., as borrower, Lantheus MI Intermediate, Inc. and Lantheus MI Real Estate, LLC, as guarantors, Bank of Montreal, as administrative agent, Harris N.A., as collateral agent and the other lenders party thereto.	
 
2

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 	LANTHEUS MEDICAL IMAGING, INC.	
 	 	 	
 	By:	/s/ Michael P. Duffy	
 	Name:	Michael P. Duffy	
 	Title:	Vice President and General Counsel	

Date: January 30, 2012	 	 	
 
3

 
EXHIBIT INDEX
 
Exhibit
Number	 	Description of Exhibits	
10.1	 	Amendment No. 2 to Credit Agreement, dated as of January 26, 2012, among Lantheus Medical Imaging, Inc., as borrower, Lantheus MI Intermediate, Inc. and Lantheus MI Real Estate, LLC, as guarantors, Bank of Montreal, as administrative agent, Harris N.A., as collateral agent and the other lenders party thereto.	
 
4

Exhibit 10.1
 
AMENDMENT NO. 2
 
TO
 
CREDIT AGREEMENT
 
AMENDMENT NO. 2, dated as of January 26, 2012 (this “Amendment”), to the Credit Agreement dated as of May 10, 2010 (as amended pursuant to that certain Amendment No. 1 dated as of March 21, 2011 and as the same may be further amended, restated, supplemented or otherwise modified from time to time, the “ Credit Agreement ”) by and among LANTHEUS MEDICAL IMAGING, INC., a Delaware corporation (“ Borrower ”), LANTHEUS MI INTERMEDIATE, INC. (“ Lantheus MI ”) and LANTHEUS MI REAL ESTATE, LLC (“ Lantheus Real Estate ” and together with Lantheus MI, the “ Guarantors ”), Bank of Montreal, as administrative agent (in such capacity, the “ Administrative Agent ”), Harris N.A., as collateral agent (in such capacity, the “ Collateral Agent ”), the Lenders from time to time party thereto and the other parties thereto.
 
W I T N E S S E T H:
 
WHEREAS, the Loan Parties, the Lenders, the Collateral Agent and the Administrative Agent wish to make certain amendments to the Credit Agreement on the terms and subject to the conditions herein provided;
 
NOW, THEREFORE, in consideration of the premises and the agreements, provisions and covenants herein contained, the parties hereto agree as follows:
 
SECTION 1.           DEFINITIONS
 
Capitalized terms used but not defined in this Amendment shall have the meanings that are set forth in the Credit Agreement.
 
SECTION 2.           AMENDMENTS
 
Effective as of the SecondAmendmentEffective Date (as defined below) and subject to the satisfaction (or due waiver) of the conditions set forth in Section 3 of this Amendment, the Credit Agreement is hereby amended as follows:
 
(a)           Subsection (a) of the definition of “Consolidated EBITDA” in Section 1.01 of the Credit Agreement is hereby amended and restated in its entirety to read as follows:
 
“(a)         the Consolidated Net Income of such Person and its Subsidiaries for such period, (i) plus without duplication, the sum of the following amounts of such Person and its Subsidiaries for such period and to the extent deducted in determining Consolidated Net Income of such Person for such period:  (A) Consolidated Net Interest Expense and, to the extent not included therein, agency fees paid to the Administrative Agent or the Collateral Agent,

 
(B) taxes based on income or profits, (C) depreciation expense (excluding depreciation of prepaid cash expenses that were paid in a prior period and added back), (D) amortization expense (excluding amortization of prepaid cash expenses that were paid in a prior period and added back), (E) up to $4,000,000 (as such amount may be increased from time to time by the Administrative Agent in its sole discretion) of legal costs incurred by the Borrower in any trailing twelve month period in connection with the Borrower making a claim under its policy of business interruption insurance, (F) to the extent actually paid during such period, any reasonable, non-recurring, out-of-pocket expenses or charges incurred in connection with any issuance (or proposed issuance) of debt or equity or any refinancing transaction (or proposed refinancing transaction) or any amendment or other modification (or proposed amendment or modification) of any debt instrument, in each case to the extent such transaction is permitted under this Agreement, (G) to the extent actually paid upon or prior to the consummation of an investment pursuant to Section 7.02(e)(xi) hereof or a Permitted Acquisition, any reasonable, non-recurring out-of-pocket fees and expenses directly related to such investment or Permitted Acquisition, but excluding consideration paid for the Capital Stock or other assets acquired in any such investment or Permitted Acquisition, (H) to the extent actually paid during such period, the amount of management, monitoring, consulting and advisory fees and related expenses paid to the Sponsor pursuant to the Management Services Agreement as in effect on the date hereof, to the extent permitted to be paid by this Agreement, (I) any impairment charge or asset write-off pursuant to Financial Accounting Standards Board Statement No. 142 or No. 144 and any amortization of intangibles arising pursuant to such Statement No. 141, (J) any non-cash tax losses attributable to the early extinguishment of any Indebtedness or other derivative instruments of the Borrower or any of its Subsidiaries, (K) the aggregate amount of all other non-cash charges reducing Consolidated Net Income, including stock-based compensation expense (excluding any such non-cash charge to the extent that it represents an accrual or reserve for potential cash items in any future period) for such period, (L) nonrecurring, reasonable, out-of-pocket expenses for the severance and recruitment of senior executives of the Parent and its Subsidiaries so long as the aggregate amount of all such expenses described in this clause (L) does not exceed $5,000,000, and (M) internal and external costs and expenses incurred to relocate, qualify and commence manufacturing operations of the Borrower from existing suppliers (including, without limitation, Ben Venue Laboratories) to new third party manufacturers and suppliers, up to an aggregate amount that does not exceed (I) $15,000,000 during any measurement period through and including the measurement period ending September 30, 2012 or (II) $17,500,000 during any measurement period thereafter, and (ii) minus (without duplication) (A) to the extent included in Consolidated Net Income, all interest income, (B) to the extent not deducted as an expense in the calculation of Consolidated Net Income, the aggregate amount paid as dividends pursuant to
 
2

 
Section 7.02(h)(A), and (C) the aggregate amount of all other non-cash items increasing Consolidated Net Income (other than (I) the accrual of revenue or recording of receivables in the ordinary course of business and (II) any non-cash item to the extent it represents the reversal of an accrual or reserve for a potential cash item in any prior period) for such period.”
 
(b)           Section 7.03(a) of the Credit Agreement is hereby amended and restated in its entirety to read as follows:
 
“(a)         Consolidated Total Leverage Ratio.  Permit the Consolidated Total Leverage Ratio of the Parent and its Subsidiaries as of the last day of each period of four (4) consecutive fiscal quarters of the Parent and its Subsidiaries to be greater than the applicable ratio set forth below:
 
Fiscal Quarter End	 	Consolidated Total Leverage
Ratio	
 	 	 	
The end of the last fiscal quarter in Fiscal Year 2011	 	5.00:1.00	
 	 	 	
The end of the first fiscal quarter in Fiscal Year 2012	 	6.80:1.00	
 	 	 	
The end of the second fiscal quarter in Fiscal Year 2012	 	7.55:1.00	
 	 	 	
The end of the third fiscal quarter in Fiscal Year 2012	 	6.70:1.00	
 	 	 	
The end of the last fiscal quarter in Fiscal Year 2012	 	5.50:1.00	
 	 	 	
The end of the first and second fiscal quarters in Fiscal Year 2013	 	4.60:1.00	
 	 	 	
The end of the third and last fiscal quarters in Fiscal Year 2013	 	4.25:1.00	
 	 	 	
The end of the first fiscal quarter in Fiscal Year 2014 and the end of each fiscal quarter thereafter	 	3.75:1.00”	
 
(c)           Section 7.03(b) of the Credit Agreement is hereby amended and restated in its entirety to read as follows:
 
“(b)         Consolidated Interest Coverage Ratio.  Permit the Consolidated Interest Coverage Ratio of the Parent and its Subsidiaries as of the last day of each period of four (4) consecutive fiscal quarters of the Parent and its Subsidiaries to be less than the applicable ratio set forth below:
 
3

 
Fiscal Quarter End	 	Consolidated Interest
Coverage Ratio	
 	 	 	
The end of the last fiscal quarter in Fiscal Year 2011	 	2.00:1.00	
 	 	 	
The end of the first fiscal quarter in Fiscal Year 2012	 	1.40:1.00	
 	 	 	
The end of the second fiscal quarter in Fiscal Year 2012	 	1.30:1.00	
 	 	 	
The end of the third fiscal quarter in Fiscal Year 2012	 	1.40:1.00	
 	 	 	
The end of the last fiscal quarter in Fiscal Year 2012	 	1.80:1.00	
 	 	 	
The end of the first fiscal quarter in Fiscal Year 2013	 	2.00:1.00	
 	 	 	
The end of the second fiscal quarter in Fiscal Year 2013	 	2.10:1.00	
 	 	 	
The end of the third and last fiscal quarters in Fiscal Year 2013	 	2.15:1.00	
 	 	 	
The end of the first fiscal quarter in Fiscal Year 2014 and the end of each fiscal quarter thereafter	 	2.25:1.00”	
 
SECTION 3.           CONDITIONS PRECEDENT TO EFFECTIVENESS
 
The amendments set forth in Section 2of this Amendment shall become effective as of the date (the “Second Amendment Effective Date ”) the following conditions precedent have been satisfied:
 
(a)           The Administrative Agent shall have received counterparts of this Amendment duly executed by the Borrower, the Guarantors, the Administrative Agent, the Collateral Agent and the Required Lenders;
 
(b)           The Administrative Agent and Lenders shall have received all fees, costs and expenses due and payable under the Credit Agreement and the other Loan Documents (including without limitation the fees and out-of-pocket expenses of legal counsel to the Administrative Agent);
 
(c)           The Administrative Agent shall have received the amendment fee set forth in Section 5 below; and
 
4

 
(d)           The representations and warranties contained in Section 4of this Amendment shall be true and correct in all material respects as of the Second Amendment Effective Date.
 
SECTION 4.           REPRESENTATIONS AND WARRANTIES
 
On and as of the SecondAmendment Effective Date, after giving effect to this Amendment and the transactions contemplated hereby, each Loan Party party hereto represents and warrants to the Administrative Agent, the Collateral Agent and the Lenders as follows:
 
4.1         Corporate Power and Authority.  Each Loan Party party hereto has all requisite power and authority to enter into this Amendment and to consummate the transactions contemplated hereby.
 
4.2         Authorization of Agreements. The execution, delivery and performance of this Amendment have been duly authorized by all necessary action on the part of each Loan Party party hereto.
 
4.3         Incorporation of Representations and Warranties from the Credit Agreement. The representations and warranties contained in ARTICLE VI of the Credit Agreement are true and correct in all material respects (except that such materiality qualifier shall not be applicable to any representations or warranties that already are qualified or modified as to “materiality” or “Material Adverse Effect” in the text thereof, which representations and warranties shall be true and correct in all respects subject to such qualification) on and as of the date hereof with the same effect as though made on and as of such date except to the extent that any such representation or warranty expressly relates solely to an earlier date (in which case such representation or warranty shall be true and correct in all material respects (except that such materiality qualifier shall not be applicable to any representations or warranties that already are qualified or modified as to “materiality” or “Material Adverse Effect” in the text thereof, which representations and warranties shall be true and correct in all respects subject to such qualification) on and as of such earlier date).
 
4.4         Absence of Default. Before and immediately after giving effect to this Amendment and the transactions contemplated hereby, no Default or Event of Default has occurred and is continuing or will result therefrom.
 
SECTION 5.           AMENDMENT FEE
 
The Borrower hereby agrees to pay to Administrative Agent, for the benefit of the Lenders who execute this Amendment, an aggregate amendment fee equal to the amount derived by multiplying 0.2% by the aggregate amount of the Revolving Credit Commitments of all of the Lenders signatory hereto.  The amendment fee shall be fully earned and payable on the date hereof, nonrefundable when paid, and shared pro rata by the Lenders signatory to this Amendment in accordance with their Pro Rata Shares.
 
5

 
SECTION 6.           MISCELLANEOUS
 
6.1         References to Credit Agreement. On and after the Second Amendment Effective Date, each reference in the Credit Agreement to “this Agreement”, “hereunder”, “hereof”, “herein” or words of like import referring to the Credit Agreement, and each reference in the other Loan Documents to the “Credit Agreement”, “thereunder”, “thereof” or words of like import referring to the Credit Agreement shall mean and be a reference to the Credit Agreement as amended by this Amendment.
 
6.2         Effect on Credit Agreement. Except as specifically amended by this Amendment, theCreditAgreement and the other Loan Documents shall remain in full force and effect and are hereby ratified and confirmed.
 
6.3         Headings.  Section headings herein are included herein for convenience of reference only and shall not constitute a part hereof for any other purpose or be given any substantive effect.
 
6.4         APPLICABLE LAW.  THIS AMENDMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES THEREOF.
 
6.5         Counterparts. This Amendment may be executed in any number of counterparts, each of which when so executed and delivered shall be deemed an original, but all such counterparts together shall constitute but one and the same instrument.  Signature pages may be detached from multiple separate counterparts and attached to a single counterpart so that all signature pages are attached to the same document.  Delivery of an executed signature page of this Amendment by facsimile transmission or electronic mail shall be as effective as delivery of a manually executed counterpart hereof.
 
6.6         Loan Document. This Amendment is a Loan Document.
 
6.7         Costs and Expenses.  The Borroweragrees to pay on demand,regardless of whether the transactions contemplated by this Amendment are consummated: all reasonable out-of-pocket costs and expenses incurred by or on behalf of each Agent, including, without limitation, reasonable fees, costs, client charges and expenses of one primary counsel for the Agents in connection with the preparation, negotiation, execution or delivery of this Amendment and any agreements contemplated hereby.
 
[Signature Pages Follow]
 
6

 
IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and delivered by their respective officers thereunto duly authorized as of the date first written above.
 
 	BORROWER:	
 	 	
 	LANTHEUS MEDICAL IMAGING, INC.	
 	 	 	
 	By:	/s/ Donald R. Kiepert	
 	 	Name: Donald R. Kiepert	
 	 	Title: President	
 	 	
 	GUARANTORS:	
 	 	
 	LANTHEUS MI INTERMEDIATE, INC.	

 	By:	/s/ Donald R. Kiepert	
 	 	Name: Donald R. Kiepert	
 	 	Title: President	

 	LANTHEUS MI REAL ESTATE, LLC	

 	By:	/s/ Donald R. Kiepert	
 	 	Name: Donald R. Kiepert	
 	 	Title: President	
 
[SIGNATURE PAGE TO AMENDMENT NO. 2 TO CREDIT AGREEMENT]

 
 	COLLATERAL AGENT:	
 	 	
 	HARRIS N.A.	
 	 	 	
 	By:	/s/ Andrew J. Pluta	
 	Name:	Andrew J. Pluta	
 	Title:	Director	

 	ADMINISTRATIVE AGENT:	
 	 	
 	BANK OF MONTREAL	
 	 	 	
 	By:	/s/ Andrew J. Pluta	
 	Name:	Andrew J. Pluta	
 	Title:	Director	

 	LENDER:	
 	 	
 	BANK OF MONTREAL	
 	 	 	
 	By:	/s/ Andrew J. Pluta	
 	Name:	Andrew J. Pluta	
 	Title:	Director	

 	NATIXIS	
 	 	 	 	
By:	/s/ Frank H. Madden, Jr.	 	By:	/s/ Tefta Ghilaga	
Name:	Frank H. Madden, Jr.	 	Name:	Tefta Ghilaga	
Title:	Managing Director	 	Title:	Director	

 	JEFFERIES FINANCE LLC	
 	 	 	
 	By:	/s/ E. Joseph Hess	
 	Name:	E. Joseph Hess	
 	Title:	Managing Director	
 
[SIGNATURE PAGE TO AMENDMENT NO. 2 TO CREDIT AGREEMENT]